Paraguay Medical Device Registration 2026: Quality Management System Evidence for Registration

1. Key takeaways

1. Article 6, item a) accepts two evidentiary routes for imported products: a BPF/GMP certificate issued by the competent authority of the country of origin, or ISO 13485 / CE / UL / FDA / TÜV / MDSAP certificates or equivalents issued by certification bodies.
2. The operating instructions state expressly that the name and address of the actual manufacturer (fabricante real) declared on the platform must match what appears in the CLV and in the ISO 13485/CE/UL/FDA/TÜV/MDSAP certificates.
3. Article 12, item a) demands the same class of evidence at renewal, which makes the quality system certificate a full-lifecycle document rather than a one-time submission. The renewal dossier is assembled inside a narrow window, and no item in it should be discovered for the first time at that moment; every recurring document must already be tracked from the day the registration is granted.
4. For national products, the BPF/GMP certificate or an equivalent such as ISO 13485 must instead be issued by DINAVISA (Article 6, national item a)).

2. Legal basis

The resolution defines which certificates are acceptable for each origin category and repeats the requirement at renewal through Article 12. The operating instructions, on pages 2 and 3, explain how the final product manufacturer field must be completed on the DINAVISAPy platform, and it is this field that anchors the name and address consistency requirement. The consistency rule has one practical consequence: the actual manufacturer named on the platform, in the CLV and in the quality system certificate must be the same legal entity at the same address. Where a group operates several sites, the certificate submitted must cover the site that actually manufactures the declared models, and the group headquarters cannot substitute for it. Verifying the three data points against each other takes minutes; repairing a mismatch after rejection costs a new acceptance cycle.

3. Expert insights

Insight one: name consistency across certificates causes more failures than the certificates themselves. The operating instructions hard-code the rule that the name and address of the actual manufacturer must match between the CLV and the quality system certificate. Group structures routinely produce mismatches: the CLV names the parent company, the ISO certificate names the factory, and the platform field is filled with the brand owner. Three different names for one manufacturing site will block the application at acceptance screening, before any technical review begins. The fix is procedural rather than legal: verify the three data points against each other before filing, and correct the underlying certificates if they disagree. The divergence is invisible in any single document, because each certificate is valid on its own and complies with its own issuing body; only the three-way comparison exposes it. In group structures the correct name is usually the licensed manufacturing site, because that is the entity the certificate bodies actually audited.

Insight two: MDSAP is expressly listed among the acceptable certificates, which makes it an efficiency lever for multi-country programs. The resolution enumerates ISO 13485 / CE / UL / FDA / TÜV / MDSAP in the text of item a). A manufacturer that already holds an MDSAP certificate can use it directly for the Paraguay submission without obtaining any separate quality system attestation, which removes one document from the critical path and one renewal obligation from the lifecycle maintenance plan. It also standardizes the quality evidence across markets, since the same audit outcome supports several submissions at once, and it reduces the number of certificates that the maintenance plan has to track through their own expiries.

Insight three: the renewal requirement shows that the quality system certificate must not lapse during the validity of the registration. Article 12, item a) lists the quality system evidence again in the renewal dossier. If the certificate expires at any point during the 10-year validity period of the registration and is not renewed, a documentary gap appears exactly when the renewal dossier is assembled, and the renewal window opens only 120 business days before expiry, which leaves very little time to repair the gap. Certificate continuity across the whole holding period is therefore a lifecycle obligation, not a registration-stage formality. A simple internal rule prevents the gap: treat the expiry of the quality system certificate as a compliance deadline in its own right, tracked alongside the registration expiry, with recertification started early enough that a failed audit still leaves room for a second attempt before the renewal window opens.

4. Practical recommendations

1. Run a three-point name and address consistency check across the CLV, the quality system certificate and the platform declaration fields before every submission, and repeat the check after every certificate renewal, since legal names and site addresses change more often than products do.
2. For multi-country programs, evaluate the reuse value of an existing MDSAP certificate before commissioning any new quality system attestation.
3. Move quality system certificate expiry management into the annual holding-period maintenance list, so continuity is checked every year and not only at renewal, recording the certificate number, the scope and the expiry date in the compliance calendar.
4. On the national route, plan the DINAVISA BPF/GMP inspection and issuance cycle well ahead of the intended filing date, since establishment certification has its own calendar, and keep a contingency margin for inspection scheduling, which rarely matches the first requested date.

5. Verification checklist

• □ Quality system certificate within its validity period
• □ Actual manufacturer name and address consistent in three places (CLV / system certificate / platform)
• □ Reuse value of the MDSAP certificate assessed
• □ Renewal dossier list includes Article 12, item a)
• □ National route: timing of DINAVISA system certificate planned

Regulatory information verified as of October 29, 2026.

GRZAN provides registration and conformity support in Paraguay for medical device manufacturers, importers and authorized representatives, including quality system evidence planning and lifecycle certificate maintenance. For assistance, contact info@grzanglobal.com.